|
Site
|
Groupa
|
Mean Score
|
Standard Deviation
|
Significanceb
|
|---|
|
Bronchus
|
A
|
1.18
|
0.85
| |
|
B
|
0.97
|
0.80
| |
|
C
|
2.29
|
0.90
|
0.001
|
|
Bronchiole
|
A
|
0.44
|
0.54
| |
|
B
|
0.50
|
0.54
| |
|
C
|
1.40
|
0.93
|
0.001
|
|
Alveolus/smooth muscle
|
A
|
0.54
|
0.61
| |
|
B
|
0.26
|
0.48
| |
|
C
|
1.73
|
1.09
|
0.001
|
|
Arteriole
|
A
|
0.80
|
0.83
| |
|
B
|
0.80
|
0.88
| |
|
C
|
2.18
|
0.96
|
0.001
|
|
Pulmonary artery
|
A
|
0.50
|
0.54
| |
|
B
|
0.73
|
0.81
| |
|
C
|
2.34
|
0.84
|
0.001
|
-
aGroup A (10): selamectin treatment initiated on Day 28 PI; Group B: (10) oral ivermectin treatment initiated Day 70 PI; Group C: infected untreated
-
bGroup C (9) was significantly different than Groups A and Group B, which were not significantly different from each other
